spacerspacerspacerspacerspacer
Center for BiosecurityUPMC | University of Pittsburgh Medical Center
horizontal rulespacer


Areas of Focus

  
Special Topics
  
Resources
The Center

 

This Website is supported by funding from the Alfred P. Sloan Foundation.
Home > Areas of Focus > BioAgents and Epidemic Diseases > Fact Sheets > Ricin Fact Sheet
Tools:||Link to this page| Share this page
horizontal rule
spacer

Ricin toxin (Ricin) PDF

(January 21, 2009)

Background

Image of castor plant
Castor plant: Ricinus communisSource: DTIRP CBW Corner.

Ricin toxin or ricin, as it is more commonly known, is a protein that consists of an A and B subunit that can be extracted from the beans of the castor plant, Ricinus communis. The castor plant originated in Asia and Africa and now grows in the southwestern region of the United States. Ricin is a byproduct of castor oil production: when castor beans are crushed, they form a pulp from which castor oil is extracted, and ricin is what remains.

Castor oil is found in many commonly used substances such as paints, varnishes, and lubricating oils, and is also used as a purgative. Its production spans the globe, but primary sources are India, China, and Brazil.1

The toxic effects of ricin are caused by its ability to inhibit protein synthesis. Ricin can be introduced to the body through inhalation of an aerosol, or through ingestion, injection or infusion. Though ricin can be lethal, it has the potential for therapeutic use because it inhibits tumor growth. Thus, it has been tested in Phase I and II clinical trials and used in combination with tumor cell-specific antibodies to treat cancer.2,3

Ricin as a Biological Weapon

Ricin was first considered for use as a biological weapon during World War I by several nations, including the United States, which gave the toxin the code name, “Compound W.” During World War II, the U.S. and Great Britain worked together to develop a “W bomb.” There is also documented use of ricin as an agent for assassination, most notably in the case of Georgi Markov, a Bulgarian exile, who, in 1978, was injected with a pellet of ricin from a spring-loaded needle that was mounted in his assassin’s umbrella. 

Image of castor beans
Castor beans. Source: USDA Natural Resources Conservation Service: Plants Profile.

Ricin has also made headlines more recently: in 2002, six suspected terrorists in Manchester, England were arrested for possessing the toxin. In 2003, a ricin-filled envelope with a letter threatening to contaminate water supplies was processed through a mail facility in Greenville, South Carolina. In 2004, traces of ricin were detected in the mail room of the Dirksen Senate Office Building in Washington, DC. And in 2008, ricin was found in a hotel room near the Las Vegas strip. The ricin belonged to a man who, at the time, fell ill and was hospitalized for unintentionally contaminating himself with the toxin.2,4,5,6

The Centers for Disease Control and Prevention (CDC) have designated ricin toxin a Category B threat agent. Category B agents are the second highest priority agents because they can be disseminated with moderate ease, they cause moderate morbidity and low mortality, and they “require specific enhancements of CDC's diagnostic capacity and enhanced disease surveillance.”7

Signs and Symptoms

Ricin exposure can occur through ingestion, parenteral means, or inhalation. Oral ingestion most commonly occurs through consumption of castor beans, though ricin can be dissolved in water or a weak acid. Ricin may also be delivered through subcutaneous, intramuscular, or intravenous injection as in the case of Georgi Markov; however, these methods are limited by proximity to the target. As a biological weapon, ricin powder or mist would most likely be aerosolized, resulting in poisoning via inhalation.

Image demonstrating lethality

The symptoms and severity of ricin poisoning are route- and dose-dependent. Generally, intoxication through inhalation of aerosolized powder or mist is the most lethal route, and oral ingestion is the least deadly route. The exact cause of death from ricin is unknown and is probably also route-specific. Ricin poisoning can lead to death within 36 to 72 hours.

Clinical Presentation of Ricin Poisoning2,5,6,7

Route of IntoxicationSigns and Symptoms
InhalationWithin a few hours of inhaling significant amounts of ricin, symptoms would include respiratory distress, fever, cough, nausea, and tightness in the chest. Patients may experience heavy sweating and pulmonary edema resulting in cyanosis. Low blood pressure and respiratory failure may occur, leading to death. Patients experiencing respiratory symptoms within 12 hours of inhaling ricin should seek medical care.
Parenteral; subcutaneous or
intramuscular injection; intravenous
Ricin is unlikely to be absorbed through intact skin, though contact may cause redness and pain of the skin and the eyes. Parenteral exposure results in fever, tachycardia, tachypnea, hypotension, hepatitis, pancreatitis, nephritis, myocardial injury, cerebral edema, vomiting, diarrhea, and bone marrow suppression.
IngestionSwallowing significant amounts of ricin may result in vomiting and diarrhea that may become bloody. Severe dehydration may result, followed by low blood pressure. Other signs or symptoms may include hallucinations, seizures, and blood in the urine. Multi-organ failure and death may follow shortly after.

  
Ricin intoxication produces a robust immune response, and patients will most likely have ricin antibodies circulating within two weeks of exposure.2 Diagnosis may be confirmed by immunological analysis of a skin or nasal swab or from samples of bodily fluids. However, these applications have not been clinically validated, and there is no widely available commercial assay for ricin in biological samples.6

Transmission

Ricin is a toxin, not a disease-causing agent; therefore, it is not contagious and cannot be spread from person to person through casual contact.

Infection Control Measures

Because there is no data on levels of respiratory protection necessary to prevent inhalational intoxication, recommendations are conservative. First responders and health care workers are urged to use the following personal protective equipment (PPE) when dealing with ricin contamination: level B PPE, self-contained breathing apparatus, disposable Tyvek suite coated with Saranex or polyethylene to prevent penetration, air purifying respirator with P-100 filter, and eye and face protection such as a full-face respirator.

PPE should be decontaminated by soaking in a 0.1% sodium hypochlorite solution for 30 minutes and washing with soap and water after use. It is not necessary for decontaminated patients to be isolated or placed in negative pressure rooms. Standard precautions should be observed.5

Prophylaxis and Treatment

There are currently no U.S. Food and Drug Administration (FDA) approved treatments specifically for ricin poisoning. Patients suffering from ricin poisoning should be provided supportive therapy.2,5,6

Decontamination

Ricin is a toxin and cannot be transmitted from human to human. However, the persistence of ricin in an environment can increase the number of individuals exposed and increase the dose that individuals receive. The higher the dose, the greater the severity of symptoms and likelihood of death. Decontamination of surfaces is therefore a necessary factor in response and can be accomplished simply by washing surfaces with 0.1% sodium hypochlorite for 30 minutes, followed by soap and water. Ricin is also a heat sensitive and can be inactivated by heat above 80 degrees centigrade (176 degrees farenheit).5

Countermeasures

There are currently no treatments specifically for ricin poisoning that are approved by the U.S. Food and Drug Administration (FDA); however, there are ricin countermeasures under development. Soligenix (formerly DOR BioPharma, Inc.) and the University of Texas Southwestern Medical Center have developed a recombinant subunit vaccine candidate, RiVaxTM, that has been “shown to be well tolerated and immunogenic in Phase I clinical trials in normal [human] volunteers.”8,9 Another trial of a formulation of RiVaxTM that includes an adjuvant is underway. Researchers in the United Kingdom’s Defence Science and Technology Laboratory have developed an anti-toxin that can provide protection from ricin poisoning up to 24 hours post-exposure. The anti-toxin is ready to be manufactured, but has not been licensed.

References

  1. Food and Agriculture Organization of the United Nations. FAOSTATA. http://faostat.fao.org/site/567/DesktopDefault.aspx?PageID=567#ancor. Accessed November 10, 2008.
  2. Spivak L, Hendrickson RG. Ricin. Crit Care Clin. 2005;21:815-824.
  3. Centers for Disease Control and Prevention. Facts about Ricin. Updated March 5, 2008. http://emergency.cdc.gov/agent/ricin/facts.asp. Accessed November 10, 2008.
  4. Friess S. In Accord, Ricin Owner Enters Plea of Guilty. The New York Times. Published: August 5, 2008. http://www.nytimes.com/2008/08/05/us/05ricin.html. Accessed November 5, 2008.
  5. Audi J, Belson M, Patel M, et al. Ricin Poisoning A Comprehensive Review. JAMA. 2005;294(18):2342-2350.
  6. Poli MA, Roy C, Huebner KD, et al. Ricin. In: Medical Aspects of Biological Warfare. U.S. Department of Defense, Office of The Surgeon General, US Army, Borden Institute. 2007:323-335. http://www.bordeninstitute.army.mil/published_volumes/biological_warfare/BW-ch15.pdf. Accessed November 5, 2008.
  7. U.S. Department of Health and Human Services: The Centers for Disease Control and Prevention. Bioterrorism Agents/Diseases (by Category). Emergency Preparedness and Response. http://emergency.cdc.gov/agent/agentlist-category.asp#b. Accessed November 10, 2008.
  8. Medical News Today. DOR BioPharma Reports Achievement Of Two-Year Stability Milestone For RiVax(TM), Its Vaccine Against Ricin Toxin.  Published January 30, 2008. http://www.medicalnewstoday.com/articles/95477.php. Accessed November 10, 2008.
  9. Smallshaw JE, Richardson JA, Vitetta, ES. RiVax, a recombinant ricin subunit vaccine, protects mice against ricing delivered by gavage or aerosol. Vaccine. 2007; 25:7459-7469.


See Also

Mirarchi FL. CBRNE- Ricin. February 14, 2008. http://emedicine.medscape.com/article/830795-overview. Accessed November 10, 2008.

U.S. Department of Health and Human Services. Response to a Ricin Incident: Guidelines for Federal, State, and Local Public Health and Medical Officials.  http://emergency.cdc.gov/agent/ricin/pdf/
ricin_protocol.pdf
. Published June 2006. Accessed November 10, 2008